These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 31930215)

  • 1. Tuberculosis drug resistance in Canada: 2018.
    LaFreniere M; Dam D; Strudwick L; McDermott S
    Can Commun Dis Rep; 2020 Jan; 46(1):9-15. PubMed ID: 31930215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tuberculosis drug resistance in Canada: 2017.
    LaFreniere M; Hussain H; Vachon J
    Can Commun Dis Rep; 2018 Nov; 44(11):290-296. PubMed ID: 30996691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tuberculosis drug resistance in Canada: 2006-2016.
    Gallant V; Vachon J; Siu W
    Can Commun Dis Rep; 2017 Nov; 43(11):236-241. PubMed ID: 29770053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tuberculosis in Canada: 1924-2012.
    Gallant V; Ogunnaike-Cooke S; McGuire M
    Can Commun Dis Rep; 2014 Mar; 40(6):99-107. PubMed ID: 29769890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidrug and extensively drug-resistant tuberculosis in Canada 1997-2008: demographic and disease characteristics.
    Minion J; Gallant V; Wolfe J; Jamieson F; Long R
    PLoS One; 2013; 8(1):e53466. PubMed ID: 23326436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A summary of tuberculosis drug resistance in Canada, 2003-2013.
    McGuire M; Gallant V; Bourgeois AC; Ogunnaike-Cooke S
    Can Commun Dis Rep; 2015 Mar; 41(Suppl 2):8-15. PubMed ID: 31713535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial use and antimicrobial resistance trends in Canada: 2014.
    Ebrahim M; Gravel D; Thabet C; Abdesselam K; Paramalingam S; Hyson C
    Can Commun Dis Rep; 2016 Nov; 42(11):227-231. PubMed ID: 29769991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberculosis in Canada: 2017.
    LaFreniere M; Hussain H; He N; McGuire M
    Can Commun Dis Rep; 2019 Feb; 45(2-3):67-74. PubMed ID: 31015821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A summary of tuberculosis in Canada, 2013.
    Gallant V; McGuire M; Ogunnaike-Cooke S
    Can Commun Dis Rep; 2015 Mar; 41(Suppl 2):2-7. PubMed ID: 31713538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug resistance among tuberculosis cases in the European Union and European Economic Area, 2007 to 2012.
    van der Werf MJ; Ködmön C; Hollo V; Sandgren A; Zucs P
    Euro Surveill; 2014 Mar; 19(10):. PubMed ID: 24650865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extensively drug-resistant tuberculosis in california, 1993-2006.
    Banerjee R; Allen J; Westenhouse J; Oh P; Elms W; Desmond E; Nitta A; Royce S; Flood J
    Clin Infect Dis; 2008 Aug; 47(4):450-7. PubMed ID: 18616396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tuberculosis in Canada, 2016.
    Vachon J; Gallant V; Siu W
    Can Commun Dis Rep; 2018 Mar; 44(3-4):75-81. PubMed ID: 31007614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidrug-resistant tuberculosis in Alberta and British Columbia, 1989 to 1998.
    Hersi A; Elwood K; Cowie R; Kunimoto D; Long R
    Can Respir J; 1999; 6(2):155-60. PubMed ID: 10322098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From multidrug- to extensively drug-resistant tuberculosis: upward trends as seen from a 15-year nationwide study.
    Stoffels K; Allix-Béguec C; Groenen G; Wanlin M; Berkvens D; Mathys V; Supply P; Fauville-Dufaux M
    PLoS One; 2013; 8(5):e63128. PubMed ID: 23671662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Investigation of extensive drug resistance in multidrug resistance tuberculosis isolates].
    Bektöre B; Haznedaroğlu T; Baylan O; Ozyurt M; Ozkütük N; Satana D; Cavuşoğlu C; Seber E
    Mikrobiyol Bul; 2013 Jan; 47(1):59-70. PubMed ID: 23390903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the socio-demographic and clinical features of pulmonary TB patients infected with sub-lineages within the W-Beijing and non-Beijing Mycobacterium tuberculosis.
    Hu Y; Mathema B; Zhao Q; Zheng X; Li D; Jiang W; Wang W; Xu B
    Tuberculosis (Edinb); 2016 Mar; 97():18-25. PubMed ID: 26980491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuberculosis in Canada - Summary 2015.
    Gallant V; Duvvuri V; McGuire M
    Can Commun Dis Rep; 2017 Mar; 43(3-4):77-82. PubMed ID: 29770069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increase in multidrug-resistant tuberculosis (MDR-TB) in Alberta among foreign-born persons: implications for tuberculosis management.
    Long R; Langlois-Klassen D
    Can J Public Health; 2013 Jan; 104(1):e22-7. PubMed ID: 23618116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug Resistance Characteristics of
    Wu X; Yang J; Tan G; Liu H; Liu Y; Guo Y; Gao R; Wan B; Yu F
    Front Cell Infect Microbiol; 2019; 9():345. PubMed ID: 31828045
    [No Abstract]   [Full Text] [Related]  

  • 20. Trends in drug-resistant tuberculosis in the United States, 1993-1996.
    Moore M; Onorato IM; McCray E; Castro KG
    JAMA; 1997 Sep; 278(10):833-7. PubMed ID: 9293991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.